rabbit polyclonal anti-th antibody ab152 (Merck KGaA)
90
Structured Review
Merck KGaA
rabbit polyclonal anti-th antibody ab152
Rabbit Polyclonal Anti Th Antibody Ab152, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+rabbit+anti-th+antibody/rabbit+anti+th/bio_rxiv__2025__03__07__641347-295-9-16
Average 90 stars, based on 1 article reviews
Rabbit Polyclonal Anti Th Antibody Ab152, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+rabbit+anti-th+antibody/rabbit+anti+th/bio_rxiv__2025__03__07__641347-295-9-16
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-th antibody ab152 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Incubation:Article Title: Combination treatment with rapamycin and glucocorticoid protects the death of mesostriatal dopaminergic neurons in animal model of Parkinson's disease. Article Snippet: Glucocorticoids have been used to treat inflammatory diseases because of their potent anti-inflammatory and immunosuppressive actions.. However, chronic use of high levels of glucocorticoids causes several adverse effects, limiting their clinical utility.. Here, we explored the therapeutic potential of a combination treatment involving reduced concentrations of rapamycin, an autophagy activator and immunosuppressant, and glucocorticoids in an animal model of Parkinson’s disease (PD). Saline:Article Title: Combination treatment with rapamycin and glucocorticoid protects the death of mesostriatal dopaminergic neurons in animal model of Parkinson's disease. Article Snippet: Glucocorticoids have been used to treat inflammatory diseases because of their potent anti-inflammatory and immunosuppressive actions.. However, chronic use of high levels of glucocorticoids causes several adverse effects, limiting their clinical utility.. Here, we explored the therapeutic potential of a combination treatment involving reduced concentrations of rapamycin, an autophagy activator and immunosuppressant, and glucocorticoids in an animal model of Parkinson’s disease (PD). Avidin-Biotin Assay:Article Title: Combination treatment with rapamycin and glucocorticoid protects the death of mesostriatal dopaminergic neurons in animal model of Parkinson's disease. Article Snippet: Glucocorticoids have been used to treat inflammatory diseases because of their potent anti-inflammatory and immunosuppressive actions.. However, chronic use of high levels of glucocorticoids causes several adverse effects, limiting their clinical utility.. Here, we explored the therapeutic potential of a combination treatment involving reduced concentrations of rapamycin, an autophagy activator and immunosuppressant, and glucocorticoids in an animal model of Parkinson’s disease (PD). |